MANUFACTURER OF RISPERDAL

A subsidiary of Johnson & Johnson first introduced Risperdal on the market in 1994. Since then, many lawsuits have been filed against the manufacturer.

The Risperdal lawsuits filed alleged that the Food and Drug Administration (FDA) originally approved the drug for a limited number of disorders such as schizophrenia, and not for disorders such as autism.

It has been argued in these cases that the FDA warned the manufacturer of the dangers of the use of Risperdal by the elderly and in younger patients. Despite the admonitions by the FDA, the manufacturer of the drug continued to market Risperdal very aggressively and broadly.

Risperdal is an approved medication that is prescribed for schizophrenia and bipolar disorder. At its inception, Risperdal was provided to only adults and teenagers that are at least 13 years or older. Thereafter, the medication has been prescribed for the treatment of disorders in adolescents who have autism. The drug Risperdal affects the manner in which the body creates hormones.

Because of this, children whose bodies are still growing and maturing are particularly vulnerable to significant hormonal changes. In many cases, male patients taking Risperdal have reported breast enlargement and serious psychological problems.

If someone in your family has suffered from enlargement of the breasts after taking Risperdal, you should contact an experienced Risperdal lawyer today. An experienced dangerous drugs attorney will fight to make a claim and diligently seek to protect your rights and interests.